Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical endpoints - Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical endpoints - Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)

Saved in:
Bibliographic Details
Published in:The American heart journal Vol. 198; pp. 152 - 159
Main Authors: Bergmeijer, Thomas O., Reny, Jean-Luc, Pakyz, Ruth E., Gong, Li, Lewis, Joshua P., Kim, Eun-Young, Aradi, Daniel, Fernandez-Cadenas, Israel, Horenstein, Richard B., Lee, Ming Ta Michael, Whaley, Ryan M., Montaner, Joan, Gensini, Gian Franco, Cleator, John H., Chang, Kiyuk, Holmvang, Lene, Hochholzer, Willibald, Roden, Dan M., Winter, Stefan, Altman, Russ B., Alexopoulos, Dimitrios, Kim, Ho-Sook, Déry, Jean-Pierre, Gawaz, Meinrad, Bliden, Kevin, Valgimigli, Marco, Marcucci, Rossella, Campo, Gianluca, Schaeffeler, Elke, Dridi, Nadia P., Wen, Ming-Shien, Shin, Jae Gook, Simon, Tabassome, Fontana, Pierre, Giusti, Betti, Geisler, Tobias, Kubo, Michiaki, Trenk, Dietmar, Siller-Matula, Jolanta M., ten Berg, Jurriën M., Gurbel, Paul A., Hulot, Jean-Sebastien, Mitchell, Braxton D., Schwab, Matthias, Ritchie, Marylyn DeRiggi, Klein, Teri E., Shuldiner, Alan R.
Format: Journal Article
Language:English
Published: 17-12-2017
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2017.12.010